|
US4673574A
(en)
|
1981-08-31 |
1987-06-16 |
Anderson Porter W |
Immunogenic conjugates
|
|
US5097020A
(en)
|
1983-07-05 |
1992-03-17 |
The University Of Rochester |
Immunogenic conjugates
|
|
US4695624A
(en)
|
1984-05-10 |
1987-09-22 |
Merck & Co., Inc. |
Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
|
|
US4882317A
(en)
|
1984-05-10 |
1989-11-21 |
Merck & Co., Inc. |
Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
|
|
US5371197A
(en)
|
1991-09-24 |
1994-12-06 |
Merck & Co., Inc. |
Protein-dimeric polysaccharide conjugate vaccine
|
|
FR2682388B1
(fr)
|
1991-10-10 |
1995-06-09 |
Pasteur Merieux Serums Vacc |
Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal.
|
|
CA2142981C
(en)
*
|
1992-08-31 |
2007-10-23 |
Joseph Y. Tai |
Vaccines against group c neisseria meningitidis
|
|
US5425946A
(en)
|
1992-08-31 |
1995-06-20 |
North American Vaccine, Inc. |
Vaccines against group C Neisseria meningitidis
|
|
ATE241384T1
(de)
|
1995-03-22 |
2003-06-15 |
Jackson H M Found Military Med |
Herstellung von immunogenen konstrukten unter verwendung von löslichen kohlehydraten, die durch organische cyanylierungs-reagenzien aktiviert wurden
|
|
US20030157129A1
(en)
|
1995-06-23 |
2003-08-21 |
Smithkline Beecham Biologicals S.A. |
Vaccine comprising a polysaccharide antigen - carrier protein conjugate and free carrier protein
|
|
US6309646B1
(en)
|
1996-05-09 |
2001-10-30 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Protein-polysaccharide conjugate vaccines and other immunological reagents prepared using homobifunctional and heterobifunctional vinylsulfones, and processes for preparing the conjugates
|
|
US5965714A
(en)
|
1997-10-02 |
1999-10-12 |
Connaught Laboratories, Inc. |
Method for the covalent attachment of polysaccharides to protein molecules
|
|
US7018637B2
(en)
|
1998-02-23 |
2006-03-28 |
Aventis Pasteur, Inc |
Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
|
|
CA2264970A1
(en)
|
1998-03-10 |
1999-09-10 |
American Cyanamid Company |
Antigenic conjugates of conserved lipolysaccharides of gram negative bacteria
|
|
US6645503B1
(en)
|
1998-03-10 |
2003-11-11 |
Wyeth Holdings Corporation |
Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria
|
|
NZ509986A
(en)
|
1998-08-19 |
2003-10-31 |
Baxter Healthcare S |
Immunogenic beta-propionamido-linked polysaccharide and oligosaccharide protein conjugates as vaccines
|
|
US6585973B1
(en)
|
1998-10-29 |
2003-07-01 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Method for preparing solid phase conjugated vaccine
|
|
US6146902A
(en)
|
1998-12-29 |
2000-11-14 |
Aventis Pasteur, Inc. |
Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
|
|
FR2791895B1
(fr)
|
1999-03-23 |
2001-06-15 |
Pasteur Merieux Serums Vacc |
Utilisation de trehalose pour stabiliser un vaccin liquide
|
|
BR0010721A
(pt)
|
1999-05-19 |
2002-06-11 |
Chiron Spa |
Composições de neisserias combinadas
|
|
US6309633B1
(en)
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
|
GB9928196D0
(en)
|
1999-11-29 |
2000-01-26 |
Chiron Spa |
Combinations of B, C and other antigens
|
|
DE10012370A1
(de)
|
2000-03-14 |
2001-09-27 |
Chiron Behring Gmbh & Co |
Adjuvans für Vakzinen
|
|
OA12302A
(en)
|
2000-06-29 |
2003-10-24 |
Glaxosmithkline Biolog Sa |
Multivalent vaccine composition.
|
|
US6673905B2
(en)
|
2000-08-09 |
2004-01-06 |
The United States Of America As Represented By The Department Of Health And Human Services |
Conjugation of biomolecules using Diels-Alder cycloaddition
|
|
EP2957300B1
(en)
*
|
2001-01-23 |
2021-07-14 |
Sanofi Pasteur Inc. |
Multivalent meningococcal polysaccharide-protein conjugate vaccine
|
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
|
WO2003009869A1
(en)
|
2001-07-26 |
2003-02-06 |
Chiron Srl. |
Vaccines comprising aluminium adjuvants and histidine
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
CU23031A1
(es)
|
2002-01-24 |
2005-02-23 |
Ct Ingenieria Genetica Biotech |
Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes
|
|
WO2003080678A1
(en)
|
2002-03-26 |
2003-10-02 |
Chiron Srl |
Modified saccharides having improved stability in water
|
|
AU2002309259A1
(en)
|
2002-05-09 |
2003-11-11 |
Massimo Porro |
Improved polysaccharide and glycoconjugate vaccines_____________
|
|
WO2004033623A2
(en)
|
2002-05-16 |
2004-04-22 |
Aventis Pasteur, Inc. |
Animal component free meningococcal polysaccharide fermentation and seedbank development
|
|
AU2003257003A1
(en)
|
2002-07-30 |
2004-02-16 |
Baxter Healthcare S.A. |
Chimeric multivalent polysaccharide conjugate vaccines
|
|
GB0220198D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Modified saccharides,conjugates thereof and their manufacture
|
|
DK1556477T3
(en)
|
2002-11-01 |
2017-10-23 |
Glaxosmithkline Biologicals Sa |
Process for drying
|
|
DK1587537T3
(da)
|
2003-01-30 |
2012-07-16 |
Novartis Ag |
Injicerbare vacciner mod multiple meningococ-serogrupper
|
|
JP2006528936A
(ja)
|
2003-05-07 |
2006-12-28 |
アヴェンティス パストゥール インコーポレイテッド |
多価髄膜炎菌誘導体化多糖−タンパク質複合体およびワクチン
|
|
US6933137B2
(en)
|
2003-05-16 |
2005-08-23 |
Aventis Pasteur |
Animal component free meningococcal polysaccharide fermentation and seedbank development
|
|
CA2530363C
(en)
|
2003-06-23 |
2013-05-07 |
Baxter International Inc. |
Carrier proteins for vaccines
|
|
BRPI0411815A
(pt)
|
2003-06-23 |
2006-08-08 |
Baxter Int |
vacinas contra neisseria meningitidis do tipo y e suas combinações meningocócicas
|
|
US8048432B2
(en)
|
2003-08-06 |
2011-11-01 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Polysaccharide-protein conjugate vaccines
|
|
AU2004281630A1
(en)
|
2003-08-06 |
2005-04-28 |
Bio-Manguinhos/Fiocruz |
Process for preparing polysaccharide-protein conjugate vaccines
|
|
KR101113726B1
(ko)
|
2003-08-12 |
2012-02-27 |
리폭센 테크놀로지즈 리미티드 |
단백질 유도 및 컨쥬게이션용 시알산 유도체
|
|
GB0323103D0
(en)
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
|
SI1670506T1
(sl)
|
2003-10-02 |
2013-03-29 |
Novartis Ag |
Tekoča cepiva proti multiplim meningokoknim seroskupinam
|
|
CU23236A1
(es)
|
2003-12-03 |
2007-09-26 |
Ct Ingenieria Genetica Biotech |
PROTEINA NMB0928 Y SU USO EN FORMULACIONES FARMACéUTICAS P
|
|
GB0409745D0
(en)
|
2004-04-30 |
2004-06-09 |
Chiron Srl |
Compositions including unconjugated carrier proteins
|
|
GB0500787D0
(en)
|
2005-01-14 |
2005-02-23 |
Chiron Srl |
Integration of meningococcal conjugate vaccination
|
|
SI1740217T1
(sl)
|
2004-04-30 |
2011-10-28 |
Novartis Ag |
Konjugirano meningokokno cepljenje
|
|
GB0413868D0
(en)
|
2004-06-21 |
2004-07-21 |
Chiron Srl |
Dimensional anlaysis of saccharide conjugates
|
|
WO2006016168A2
(en)
|
2004-08-12 |
2006-02-16 |
Lipoxen Technologies Limited |
Sialic acid derivatives
|
|
AU2005279821A1
(en)
|
2004-08-30 |
2006-03-09 |
Sanofi Pasteur, Inc. |
Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
|
|
CA2580693A1
(en)
|
2004-09-21 |
2006-03-30 |
Sanofi Pasteur, Inc. |
Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
|
|
WO2006042542A2
(en)
|
2004-10-19 |
2006-04-27 |
Statens Serum Institut |
Production of tetanus, diphtheria, and pertussis toxins and toxoids using fermentation media containing no components of animal or soy origin
|
|
GB0505518D0
(en)
|
2005-03-17 |
2005-04-27 |
Chiron Srl |
Combination vaccines with whole cell pertussis antigen
|
|
NZ563940A
(en)
|
2005-05-06 |
2010-11-26 |
Novartis Vaccines & Diagnostic |
Immunogens for meningitidis-A vaccines comprising oligosaccharides linked by a phosphonate
|
|
GB0513069D0
(en)
*
|
2005-06-27 |
2005-08-03 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
US9486515B2
(en)
|
2005-06-27 |
2016-11-08 |
Glaxosmithkline Biologicals S.A. |
Immunogenic composition
|
|
GB0513071D0
(en)
*
|
2005-06-27 |
2005-08-03 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
AU2012203419B2
(en)
*
|
2005-06-27 |
2014-06-26 |
Glaxosmithkline Biologicals S.A. |
Immunogenic composition
|
|
CA2621023C
(en)
|
2005-09-01 |
2019-07-02 |
Novartis Vaccines And Diagnostics Gmbh & Co. Kg |
Multiple vaccination including serogroup c meningococcus
|
|
CA2621578C
(en)
|
2005-09-05 |
2014-07-22 |
Glaxosmithkline Biologicals S.A. |
Serum bactericidal assay for n. meningitidis specific antisera
|
|
JP2009521434A
(ja)
|
2005-12-22 |
2009-06-04 |
サノフィ パストゥール インコーポレイテッド |
髄膜炎菌由来の誘導体化多糖類−タンパク質の多価コンジュゲートおよびワクチン
|
|
CN103251940A
(zh)
|
2005-12-22 |
2013-08-21 |
葛兰素史密丝克莱恩生物有限公司 |
疫苗
|
|
WO2007084856A2
(en)
|
2006-01-13 |
2007-07-26 |
Baxter International Inc. |
Method for purifying polysaccharides
|
|
CA2644724C
(en)
|
2006-03-17 |
2016-05-24 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Methods for preparing complex multivalent immunogenic conjugates
|
|
AU2007229449A1
(en)
|
2006-03-22 |
2007-10-04 |
Novartis Ag |
Regimens for immunisation with meningococcal conjugates
|
|
CU23575A1
(es)
|
2006-03-31 |
2010-09-30 |
Ct Ingenieria Genetica Biotech |
Composición farmacéutica que comprende la proteína nmb0606
|
|
CU23572A1
(es)
|
2006-03-31 |
2010-09-30 |
Ct Ingenieria Genetica Biotech |
Composición farmacéutica que comprende la proteína nmb0938
|
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
|
EP2032161B1
(en)
|
2006-06-12 |
2012-07-11 |
GlaxoSmithKline Biologicals S.A. |
L3v los vaccines
|
|
US7491517B2
(en)
|
2006-07-19 |
2009-02-17 |
Jeeri R Reddy |
Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135
|
|
EP2056871B1
(en)
|
2006-08-07 |
2017-11-15 |
President and Fellows of Harvard College |
Protein matrix vaccines and methods of making and administering such vaccines
|
|
GB0700135D0
(en)
*
|
2007-01-04 |
2007-02-14 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
GB0700136D0
(en)
|
2007-01-04 |
2007-02-14 |
Glaxosmithkline Biolog Sa |
Process for manufacturing vaccines
|
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
|
US8398985B2
(en)
|
2007-04-23 |
2013-03-19 |
Serum Institute Of India Ltd. |
Antigenic polysaccharides and process for their preparation
|
|
ES2555786T3
(es)
|
2007-06-04 |
2016-01-08 |
Glaxosmithkline Biologicals Sa |
Formulación de vacunas contra la meningitis
|
|
CN105267974A
(zh)
|
2007-06-20 |
2016-01-27 |
辉瑞爱尔兰制药公司 |
用于缀合疫苗的经过修饰的多糖
|
|
JP5702600B2
(ja)
|
2007-07-03 |
2015-04-15 |
チルドレンズ ホスピタル アンド リサーチ センター アット オークランド |
オリゴシアル酸誘導体、製造方法および免疫学的使用
|
|
GB0713880D0
(en)
|
2007-07-17 |
2007-08-29 |
Novartis Ag |
Conjugate purification
|
|
BRPI0818545A2
(pt)
|
2007-10-19 |
2017-07-04 |
Novartis Ag |
formulações de vacinais meningocócicas
|
|
KR101695800B1
(ko)
|
2008-03-05 |
2017-02-22 |
사노피 파스퇴르 |
항원보강제 함유 백신 조성물의 안정화 방법
|
|
GB0810894D0
(en)
|
2008-06-13 |
2008-07-23 |
Novartis Vaccines & Diagnostic |
Conjugated saccharide
|
|
KR20150041178A
(ko)
|
2008-07-21 |
2015-04-15 |
더 브리검 앤드 우먼즈 하스피털, 인크. |
합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물
|
|
GB0822633D0
(en)
|
2008-12-11 |
2009-01-21 |
Novartis Ag |
Formulation
|
|
JP5841044B2
(ja)
|
2009-03-23 |
2016-01-06 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． |
複合糖質ワクチン
|
|
CN102596240B
(zh)
|
2009-08-27 |
2015-02-04 |
诺华股份有限公司 |
包括脑膜炎球菌fHBP序列的杂交多肽
|
|
US20130022633A1
(en)
|
2009-10-27 |
2013-01-24 |
University Of Florence |
MENINGOCOCCAL fHBP POLYPEPTIDES
|
|
JP5781542B2
(ja)
|
2009-12-30 |
2015-09-24 |
ノバルティス アーゲー |
Ｅ．ｃｏｌｉキャリアタンパク質に結合体化した多糖免疫原
|
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
|
US10478483B2
(en)
*
|
2010-06-25 |
2019-11-19 |
Glaxosmithkline Biologicals Sa |
Combinations of meningococcal factor H binding proteins
|
|
US9120848B2
(en)
|
2010-09-23 |
2015-09-01 |
Harvey Kaplan |
Non-aqueous synthesis of polysaccharide-protein conjugates for vaccines
|
|
KR20140026392A
(ko)
*
|
2011-03-02 |
2014-03-05 |
노파르티스 아게 |
저용량의 항원 및/또는 보조제를 갖는 조합 백신
|
|
GB201103836D0
(en)
|
2011-03-07 |
2011-04-20 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
|
ES2728653T3
(es)
|
2011-05-18 |
2019-10-28 |
Matrivax Inc |
Composiciones vacunales con una matriz proteica que incluye policationes
|
|
CN103917245B
(zh)
|
2011-09-14 |
2017-06-06 |
葛兰素史密丝克莱恩生物有限公司 |
用于制备糖‑蛋白质糖缀合物的方法
|
|
US9493517B2
(en)
|
2011-11-07 |
2016-11-15 |
Glaxosmithkline Biologicals Sa |
Conjugates comprising an antigen and a carrier molecule
|
|
GB2495341B
(en)
|
2011-11-11 |
2013-09-18 |
Novartis Ag |
Fermentation methods and their products
|
|
IN2012MU00206A
(enExample)
*
|
2012-01-20 |
2013-08-09 |
|
|
|
HUE040914T4
(hu)
*
|
2012-01-30 |
2019-05-28 |
Serum Institute Of India Pvt Ltd |
Immunogén készítmény
|
|
MY167723A
(en)
|
2012-03-09 |
2018-09-21 |
Pfizer |
Neisseria meningitidis compositions and methods thereof
|
|
EP2852414B9
(en)
|
2012-05-22 |
2020-12-09 |
GlaxoSmithKline Biologicals SA |
Meningococcus serogroup x conjugate
|
|
US9427476B2
(en)
|
2012-05-24 |
2016-08-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Multivalent meningococcal conjugates and methods for preparing conjugates
|
|
CN104602696A
(zh)
|
2012-05-30 |
2015-05-06 |
布赖汉姆妇女医院 |
多糖组合物及使用方法
|
|
CN104487086B
(zh)
|
2012-07-07 |
2019-08-30 |
巴拉特生物技术国际有限公司 |
无动物源的不含酒精的疫苗组合物及其制备方法
|
|
HUE049531T2
(hu)
|
2012-08-16 |
2020-10-28 |
Pfizer |
Glikokonjugációs eljárások és kompozíciók
|
|
CN102809656B
(zh)
|
2012-08-26 |
2014-09-03 |
云南沃森生物技术股份有限公司 |
一种脑膜炎球菌多糖结合疫苗成品各群游离多糖含量的测定方法
|
|
BR112015005056A2
(pt)
*
|
2012-09-06 |
2017-11-21 |
Novartis Ag |
vacinas de combinação com sorogrupo b meningococcus e d/t/p
|
|
CA2885625A1
(en)
|
2012-10-02 |
2014-04-10 |
Glaxosmithkline Biologicals S.A. |
Nonlinear saccharide conjugates
|
|
EP2922569B1
(en)
|
2012-11-21 |
2018-01-03 |
Serum Institute of India Private Limited |
Production of high yields of bacterial polysaccharides
|
|
KR101980989B1
(ko)
|
2012-12-20 |
2019-05-21 |
화이자 인코포레이티드 |
당접합 방법
|
|
ITMI20130142A1
(it)
|
2013-01-31 |
2014-08-01 |
Biosynth Srl |
Vaccini glicoconiugati comprendenti unita' di base di un costrutto molecolare esprimente epitopi multipli incorporati
|
|
AU2014234408B2
(en)
*
|
2013-03-18 |
2017-04-20 |
Glaxosmithkline Biologicals S.A. |
Method of treatment
|
|
CN105431446A
(zh)
|
2013-05-20 |
2016-03-23 |
桑塔生物科技私人有限公司 |
多糖蛋白质结合物的纯化
|
|
WO2014210564A1
(en)
|
2013-06-27 |
2014-12-31 |
Academia Sinica |
Glycan conjugates and use thereof
|
|
KR20160040556A
(ko)
|
2013-07-11 |
2016-04-14 |
노파르티스 아게 |
미생물 트랜스글루타미나제를 사용한 리신-특이적 화학효소적 단백질 변형
|
|
WO2015052684A2
(en)
|
2013-10-11 |
2015-04-16 |
Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. |
Polysaccharide-protein conjugates with enhanced immunogenicity and rapid high yielding process thereof
|
|
WO2015084846A1
(en)
|
2013-12-02 |
2015-06-11 |
Brandeis University |
High temperature selection of nucleotide-supported carbohydrate vaccines and resulting glycosylated oligonucleotides
|
|
ES2930318T3
(es)
|
2014-02-14 |
2022-12-09 |
Pfizer |
Conjugados glucoproteicos inmunogénicos
|
|
MY186874A
(en)
|
2014-02-25 |
2021-08-26 |
Msd Wellcome Trust Hilleman Laboratories Pvt Ltd |
A novel downstream process for purifying polysaccharides
|
|
CN106061986B
(zh)
|
2014-02-25 |
2020-07-07 |
默沙东和惠康基金会合资的希勒曼实验室私人有限公司 |
脑膜炎奈瑟菌血清组x的新的合成寡聚体及其制备方法
|
|
EP3131576B1
(en)
|
2014-04-17 |
2021-06-30 |
Medizinische Hochschule Hannover |
Means and methods for producing neisseria meningitidis capsular polysaccharides of low dispersity
|
|
CN104069504B
(zh)
|
2014-05-11 |
2019-09-24 |
江苏康泰生物医学技术有限公司 |
一种增强多糖蛋白结合物免疫原性的方法
|
|
US10420833B2
(en)
|
2014-05-19 |
2019-09-24 |
Board Of Regents, The University Of Texas System |
Combinatorial platform for the display of surface adjuvants and antigens
|
|
ES2865485T3
(es)
|
2014-05-24 |
2021-10-15 |
Biological E Ltd |
Nueva vacuna de conjugado meningocócico semisintético
|
|
EA201700177A1
(ru)
*
|
2014-10-09 |
2017-07-31 |
Мсд Уэлком Траст Хиллеман Лабораторис Пвт. Лтд. |
Улучшенный способ конъюгирования и полученные с помощью него новые синтетические конъюгаты олигосахарида с белком
|
|
US10888611B2
(en)
|
2015-02-19 |
2021-01-12 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
BR112017023437B1
(pt)
|
2015-04-28 |
2022-03-22 |
Biological E Limited |
Métodos para o isolamento de polissacarídeo capsular de bactérias e composição imunogênica
|
|
CN104998255B
(zh)
|
2015-06-30 |
2018-08-28 |
北京祥瑞生物制品有限公司 |
新型acyw135群脑膜炎球菌结合疫苗及其制备方法
|
|
US10543266B2
(en)
|
2015-07-04 |
2020-01-28 |
Bharat Biotech International Ltd. |
Polysaccharide vaccine formulations and processes for industrial production of bacterial polysaccharides
|
|
CN105061629A
(zh)
|
2015-08-31 |
2015-11-18 |
成都欧林生物科技股份有限公司 |
A群脑膜炎球菌荚膜粗多糖纯化工艺
|
|
RU2021135165A
(ru)
|
2015-11-17 |
2021-12-29 |
Пфайзер Инк. |
Среды и способы ферментации для производства полисахаридов в бактериальной клеточной культуре
|
|
WO2017158480A1
(en)
|
2016-03-15 |
2017-09-21 |
Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. |
Novel polysaccharide-protein conjugates and process to obtain thereof
|
|
AU2017321863B2
(en)
|
2016-09-02 |
2024-07-11 |
Sanofi Vaccines US Inc. |
Neisseria meningitidis vaccine
|
|
EP3585427A4
(en)
|
2017-02-24 |
2020-12-30 |
Merck Sharp & Dohme Corp. |
METHODS FOR IMPROVING THE FILTRABILITY OF POLYSACCHARIDE CONJUGATE WITH PROTEIN REACTIONS
|